Latest Stock Split Details
Key information about Lakewood-Amedex Biotherapeutics Inc. Common Stock's most recent stock split
Developer API
Get LABT split history as JSON
Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 10.00 times fewer shares (a 1:10 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Lakewood-Amedex Biotherapeutics Inc. Common Stock's stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2026-06-22 | 1:10 | Yes | $0.36 | $0.04 |
About Lakewood-Amedex Biotherapeutics Inc. Common Stock
Company overview and industry information
Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) operates in the Biotechnology industry. The recent 1-for-10 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.